Interleukin-4 (IL-4) is a multifunctional type I cytokine that mediates its function through a heterodimeric receptor consisting of the IL-4 receptor (R) alpha chain and the gammac chain. IL-4 mediated growth regulation depends upon an IL-4R alpha receptor domain centering on Y497. When Y497 is phosphorylated, it acts as a docking site for a series of PTB-domain-containing proteins including IRS-1, IRS-2, Shc, and the newly identified IL-4 receptor interacting protein (FRIP). IRS-1, IRS-2 and Shc mediate their function, in part, by enhancing the action of the RAS pathway, through the conversion of RAS-GDP to RAS-GTP. FRIP is a PTB-domain containing protein that binds to RAS-GAP. RAS-GAP catalyzes the hydrolysis of RAS-GTP to RAS-GDP and thus limits growth mediated through the RAS pathway. Results drawn from the study of mice expressing low levels of FRIP suggest that the IL-4 mediated phosphorylation of FRIP down-regulates IL-4-induced growth, implying that FRIP enhances the activity of RAS-GAP. These results strongly suggest that IL-4-mediated growth regulation is under very strong positive and negative regulation, both depending upon substrate phosphorylation mediated by receptor activation. This type of regulation could provide a mechanism for the precise tuning of IL-4-mediated growth. FRIP has recently been shown to be phosphorylated in response to IL-2 and IL-3; preliminary results suggest it is also activated by the T cell receptor, indicating that it may have very broad activities in regulating lymphocyte growth control. IL-4-mediated gene activation and differentiation depend upon an independent domain of the IL-4Ralpha chain containing three STAT-6 binding sites. Development of naive T cells into IL-4-producing cells is dependent upon IL-4 itself. IL-4Ralpha chain knockout mice display a major impairment in the development of TH2-type immune responses in response to infection with Nippostrongylus brasiliensis. These mice do possess a set of CD4+, CD62L-low cells that can secrete some IL-4 in response to stimulation with anti-CD3; these cells may be a set of conventional T cells that can become IL-4-producers without a requirement for IL-4 and may act to aid naive cells to develop into IL-4 producing TH2 cells. A second population potentially important in this respect are CD4+, NK1.1+ T cells, largely specific for CD-1 and enriched in cells that use Vbeta8 and Valpha14 chains in their T cell receptors. These cells are numerous among liver, Peyer's patch and portal blood T cells, suggesting that they play a particularly important role in immune responses mediated by gut lymphoid tissue. Interestingly, they are rare in mesenteric lymph node and, indeed, among all lymph node cells. A population of CD4+ T cells that have essentially identical properties, except that they lack the expression of NK1.1, are found in normal mice in a frequency similar to those that do express NK1.1. The development of naive TH precursor cells into TH1 and TH2 cells is a highly regulated process, with the acquisition of IL-4 and IFNgamma-producing activities being independently controlled. Fully differentiated TH1 cells fail to acquire IL-4-producing capacity even when cultured with antigen in the presence of IL-4. It has now been shown that fully differentiated TH1 cells display a desensitized IL-4R. IL-4 fails to elicit STAT-6 phosphorylation in such cells. Interestingly, these cells also are deficient in IRS-2, as are cells of STAT-6 KO mice that have been stimulated in vitro in with IL-4. Thus, the induction of the major growth regulatory substrate phosphorylated in response to IL-4 is under the control of STAT-6, explaining how the gene activation function of the IL-4 receptor plays a role in controlling growth.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI000493-11
Application #
6160623
Study Section
Special Emphasis Panel (LI)
Project Start
Project End
Budget Start
Budget End
Support Year
11
Fiscal Year
1997
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Dewas, Cedric; Chen, Xi; Honda, Tetsuya et al. (2015) TSLP expression: analysis with a ZsGreen TSLP reporter mouse. J Immunol 194:1372-80
Paul, William E (2014) Endless fascination. Annu Rev Immunol 32:1-24
Ben-Sasson, S Z; Wang, K; Cohen, J et al. (2013) IL-1? strikingly enhances antigen-driven CD4 and CD8 T-cell responses. Cold Spring Harb Symp Quant Biol 78:117-24
Paul, William E; Milner, Joshua D; Grossman, Zvi (2013) Pathogen-sensing, regulatory T cells, and responsiveness-tuning collectively regulate foreign- and self-antigen mediated T-cell responses. Cold Spring Harb Symp Quant Biol 78:265-76
van Panhuys, Nicholas; Prout, Melanie; Forbes, Elizabeth et al. (2011) Basophils are the major producers of IL-4 during primary helminth infection. J Immunol 186:2719-28
Guo, Liying; Wei, Gang; Zhu, Jinfang et al. (2009) IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells. Proc Natl Acad Sci U S A 106:13463-8
Zhu, Jinfang; Davidson, Todd S; Wei, Gang et al. (2009) Down-regulation of Gfi-1 expression by TGF-beta is important for differentiation of Th17 and CD103+ inducible regulatory T cells. J Exp Med 206:329-41
Ben-Sasson, Shlomo Z; Hu-Li, Jane; Quiel, Juan et al. (2009) IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation. Proc Natl Acad Sci U S A 106:7119-24
Milner, Joshua D; Brenchley, Jason M; Laurence, Arian et al. (2008) Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 452:773-6
Min, Booki; Paul, William E (2008) Basophils and type 2 immunity. Curr Opin Hematol 15:59-63

Showing the most recent 10 out of 66 publications